Phoenix, Arizona. Apr. 30, 2023 — TapRoot Interventions & Solutions, Inc. (“TapRoot”), a Phoenix-based digital healthcare company, today announced the launch of a new partnership with Medtelligent, Inc., using their electronic medical record platform, ALIS, to provide senior living a one-stop, easy to use, integrated care management platform to solve everyday care management, staff scheduling, compliance, and reporting challenges for senior living communities.Continue reading
Author Archive: AZBio
Preserving the biotech social contract – we should all be pitching in
“We’re fortunate to work in an industry that benefits from decades of investment and is now brimming with possibility to improve human health. But if we don’t do our part to maintain a healthy ecosystem, we’ll find ourselves on increasingly rocky, slippery, dead-end trails”
–Steve Potts, founding CEO, Anticipate BioscienceContinue reading
Medtronic receives FDA approval for its next generation Micra leadless pacing systems
New pacemakers offer 40% more battery life, extend Medtronic legacy of pacing leadershipContinue reading
Genomic Sequencing Shows Promise in Preparation for Emerging Disuse Outbreaks
TGen scientists test new NGS technologies for utility in large-scale pandemic responses
NuvOx Receives SPAN Grant
NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with ReperfusionContinue reading
NeoLight reaches agreement to acquire InterVIEW Medical Systems, globally recognized provider of ROP education and examination
NeoLight has signed a binding agreement to acquire key assets of interVIEW Medical Systems ROP (retinopathy-of-prematurity) risk management education course and ROP risk management clinical exam, collectively called the ROP Certification Program.Continue reading
HTG Provides Update on Drug Discovery Partnering Initiative
TUCSON, Ariz., April 25, 2023 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today provided an update on partnering discussions for its drug discovery business unit.Continue reading
Circular DNA takes center stage in a deadly form of cancer, research shows
ASU joins international team to study disease evolution
Stockdale commits $20M to convert Ilume into life science lab
Stockdale Capital Partners, a Los Angeles-based, vertically-integrated real estate investment firm, is committing over $20 million on a major renovation plan to finish converting Ilume Innovation Center in Scottsdale, Arizona to be a fully lab-enabled life science facility. The renovation will also include several move-in-ready wet lab suites, and upgraded tenant amenities including a fitness center, 110-person capacity auditorium, meeting space, tenant lounge, and 1.5-acre rooftop garden.
Continue reading
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
TUCSON, Ariz., April 18, 2023 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.Continue reading